Upcoming Earnings Schedules, Stock Price Movements, and Quarterly Financial Results - Analyst Notes on Methanex, Grace, Chemtura, NewMarket, and HB Fuller

NEW YORK, April 3, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Methanex Corp. (NASDAQ: MEOH), W.R. Grace & Co. (NYSE: GRA), Chemtura Corporation (NYSE: CHMT), NewMarket Corp. (NYSE: NEU), and HB Fuller Co. (NYSE: FUL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

--

Methanex Corp. Analyst Notes 

On the corporate website of Methanex Corp. (Methanex), the Company posted the schedule for its upcoming Q1 2014 financial results. The quarterly earnings will be released on April 29, 2014, Tuesday. In conjunction with its earnings release, the Company will also host a conference call to discuss the results on April 30, 2014, Wednesday, at 9:00 a.m. PT/12:00 p.m. ET. The full analyst notes on Methanex Corp. are available to download free of charge at:

http://www.AnalystsReview.com/04032014/MEOH/report.pdf

--

W.R. Grace & Co. Analyst Notes 

On March 31, 2014, W.R. Grace & Co.'s (Grace) stock rose 0.50% to end the day at $99.17, compared to its previous day closing price of $98.68. The Company's stock grew 13.47% over the past six trading months. In comparison, the broader market indices - Dow Jones Industrial Average and S&P 500 rose 8.77% and 11.34%, respectively, during the same trading period. The full analyst notes on W.R. Grace & Co. are available to download free of charge at:

http://www.AnalystsReview.com/04032014/GRA/report.pdf

--

Chemtura Corporation Analyst Notes 

On March 24, 2014, Chemtura Corp. (Chemtura) announced the schedule of its quarterly earnings release. The Company intends to release its Q1 2014 financial results as well as file its Form 10-Q on April 30, 2014, Wednesday, after the market close. The Company will hold a conference call to discuss these results on the following day, May 1, 2014, Thursday, at 9:00 a.m. EDT. Chemtura informed that a webcast of the teleconference will be available on the Investor Relations section of its website. The full analyst notes on Chemtura Corporation are available to download free of charge at:

http://www.AnalystsReview.com/04032014/CHMT/report.pdf

--

NewMarket Corp. Analyst Notes 

On March 31, 2014, NewMarket Corp.'s (NewMarket) stock increased 1.91% to end the day at $390.78, compared to its previous day closing price of $383.46. In the last one month, the Company's stock grew 5.62%, beating the Dow Jones Industrial Average which rose 1.13%, and the S&P 500 which grew 0.97% during the same trading period. The full analyst notes on NewMarket Corp. are available to download free of charge at:

http://www.AnalystsReview.com/04032014/NEU/report.pdf

--

HB Fuller Co. Analyst Notes 

On March 26, 2014, H.B. Fuller Co. (H.B. Fuller) reported its Q1 FY 2014 financial results (period ended March 1, 2014). For the quarter, the Company reported net revenue of $486.0 million, up 1.3% YoY. Net income attributable to H.B. Fuller came in at $14.6 million, $0.28 per diluted share, compared to $20.7 million, or $0.41 per diluted share, in Q1 FY 2013. Adjusted diluted EPS was $0.49, which remained unchanged from Q1 FY 2013. Jim Owens, H.B. Fuller President and CEO said, "During the first quarter, we hit a number of key milestones on our transformation programs and we remain on track toward hitting our goal of 15 percent EBITDA margin in 2015, while still delivering the expected level of EPS during this quarter." The full analyst notes on HB Fuller Co. are available to download free of charge at:

http://www.AnalystsReview.com/04032014/FUL/report.pdf

--

About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

--

=============

EDITOR NOTES: 

• This is not company news. We are an independent source and our views do not reflect the companies mentioned.
• Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
• This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
• If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
• For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
• Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.

COMPLIANCE PROCEDURE 

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE 

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED 

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AnalystsReview.com

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED